Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

EPA:EXPL - Euronext Paris - Matif - FR0014003AQ4 - Common Stock - Currency: EUR

195.5  -1 (-0.51%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EXPL. EXPL was compared to 68 industry peers in the Chemicals industry. While EXPL has a great profitability rating, there are some minor concerns on its financial health. EXPL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

EXPL had positive earnings in the past year.
In the past year EXPL had a positive cash flow from operations.
Of the past 5 years EXPL 4 years were profitable.
EXPL had a positive operating cash flow in each of the past 5 years.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of 4.98%, EXPL is doing good in the industry, outperforming 72.06% of the companies in the same industry.
With a decent Return On Equity value of 14.04%, EXPL is doing good in the industry, outperforming 77.94% of the companies in the same industry.
The Return On Invested Capital of EXPL (6.36%) is better than 67.65% of its industry peers.
EXPL had an Average Return On Invested Capital over the past 3 years of 6.01%. This is in line with the industry average of 6.39%.
The last Return On Invested Capital (6.36%) for EXPL is above the 3 year average (6.01%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROIC 6.36%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a decent Profit Margin value of 4.77%, EXPL is doing good in the industry, outperforming 63.24% of the companies in the same industry.
EXPL's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 4.22%, EXPL perfoms like the industry average, outperforming 51.47% of the companies in the same industry.
In the last couple of years the Operating Margin of EXPL has grown nicely.
EXPL has a Gross Margin of 60.41%. This is amongst the best in the industry. EXPL outperforms 89.71% of its industry peers.
EXPL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

EXPL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, EXPL has more shares outstanding
Compared to 5 years ago, EXPL has more shares outstanding
EXPL has a better debt/assets ratio than last year.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPL has an Altman-Z score of 2.67. This is not the best score and indicates that EXPL is in the grey zone with still only limited risk for bankruptcy at the moment.
EXPL has a Altman-Z score of 2.67. This is in the better half of the industry: EXPL outperforms 66.18% of its industry peers.
The Debt to FCF ratio of EXPL is 2.38, which is a good value as it means it would take EXPL, 2.38 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.38, EXPL belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
A Debt/Equity ratio of 0.40 indicates that EXPL is not too dependend on debt financing.
EXPL has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Altman-Z 2.67
ROIC/WACC0.86
WACC7.37%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.26 indicates that EXPL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.26, EXPL is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
EXPL has a Quick Ratio of 1.26. This is a bad value and indicates that EXPL is not financially healthy enough and could expect problems in meeting its short term obligations.
EXPL's Quick ratio of 0.94 is on the low side compared to the rest of the industry. EXPL is outperformed by 61.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.64% over the past year.
EXPL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.47% yearly.
Looking at the last year, EXPL shows a small growth in Revenue. The Revenue has grown by 1.64% in the last year.
The Revenue has been growing slightly by 7.27% on average over the past years.
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%

3.2 Future

The Earnings Per Share is expected to grow by 17.28% on average over the next years. This is quite good.
EXPL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.63% yearly.
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.71 indicates a rather expensive valuation of EXPL.
69.12% of the companies in the same industry are more expensive than EXPL, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.48, EXPL is valued a bit cheaper.
With a Price/Forward Earnings ratio of 13.36, EXPL is valued correctly.
Based on the Price/Forward Earnings ratio, EXPL is valued a bit cheaper than the industry average as 69.12% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.04. EXPL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.71
Fwd PE 13.36
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

EXPL's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPL indicates a rather cheap valuation: EXPL is cheaper than 85.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.88
EV/EBITDA 10.79
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

EXPL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EXPL's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)0.91
PEG (5Y)N/A
EPS Next 2Y21.01%
EPS Next 3Y17.28%

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.77%, EXPL is not a good candidate for dividend investing.
EXPL's Dividend Yield is slightly below the industry average, which is at 3.02.
With a Dividend Yield of 0.77, EXPL pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

The dividend of EXPL decreases each year by -6.39%.
Dividend Growth(5Y)-6.39%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

9.03% of the earnings are spent on dividend by EXPL. This is a low number and sustainable payout ratio.
DP9.03%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

More info and screens

EXPLOSIFS PROD. CHI

EPA:EXPL (8/8/2025, 7:00:00 PM)

195.5

-1 (-0.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.7%
Inst Owner ChangeN/A
Ins Owners10.85%
Ins Owner ChangeN/A
Market Cap441.83M
Analysts42.22
Price Target221.34 (13.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Yearly Dividend1
Dividend Growth(5Y)-6.39%
DP9.03%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.71
Fwd PE 13.36
P/S 0.9
P/FCF 10.88
P/OCF 6.59
P/B 2.65
P/tB 2.95
EV/EBITDA 10.79
EPS(TTM)11.04
EY5.65%
EPS(NY)14.64
Fwd EY7.49%
FCF(TTM)17.96
FCFY9.19%
OCF(TTM)29.69
OCFY15.19%
SpS216.88
BVpS73.67
TBVpS66.32
PEG (NY)0.91
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROCE 7.48%
ROIC 6.36%
ROICexc 6.41%
ROICexgc 6.82%
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
FCFM 8.28%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
ROICexc(3y)6.49%
ROICexc(5y)5.43%
ROICexgc(3y)6.91%
ROICexgc(5y)5.79%
ROCE(3y)7.04%
ROCE(5y)5.85%
ROICexcg growth 3Y2.1%
ROICexcg growth 5Y14.44%
ROICexc growth 3Y2.48%
ROICexc growth 5Y15.88%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Debt/EBITDA 1.33
Cap/Depr 91.37%
Cap/Sales 5.41%
Interest Coverage 3.37
Cash Conversion 135.01%
Profit Quality 173.71%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.67
F-Score6
WACC7.37%
ROIC/WACC0.86
Cap/Depr(3y)105.91%
Cap/Depr(5y)86.48%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y22.43%
EBIT growth 3Y16.9%
EBIT growth 5Y23.09%
EBIT Next Year87.74%
EBIT Next 3Y32.42%
EBIT Next 5YN/A
FCF growth 1Y284.59%
FCF growth 3Y49.53%
FCF growth 5Y77.86%
OCF growth 1Y102.52%
OCF growth 3Y33.74%
OCF growth 5Y25.45%